Antiatherosclerotic effects of oral cicaprost in experimental hypercholesterolemia in rabbits
- 31 October 1993
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 103 (1) , 93-105
- https://doi.org/10.1016/0021-9150(93)90043-t
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: Clinical evidence from the physicians' health studyAmerican Heart Journal, 1991
- U-61, 431F, a stable prostacyclin analogue, inhibits the proliferation of bovine vascular smooth muscle cells with little antiproliferative effect on endothelial cellsProstaglandins, 1991
- Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis.Circulation, 1991
- Endothelial alterations in hypercholesterolaemia and atherosclerosisPharmacological Research, 1991
- Stimulation of vascular prostacyclin and inhibition of platelet function by oral defibrotide in cholesterol-fed rabbitsAtherosclerosis, 1989
- Pharmacokinetics of 3H-Cicaprost in healthy volunteersProstaglandins, 1989
- Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta The effect of calcium antagonistsAtherosclerosis, 1988
- Blood-vessel wall arachidonate metabolism and its pharmacological modification in a new in vitro assay systemNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analoguesBritish Journal of Pharmacology, 1986